TI
ONCR

Trexquant Investment’s Oncorus, Inc. ONCR Stock Holding History

Trexquant Investment’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23,266
Closed -$123K – 1839
2021
Q4 		$123K Sell
23,266
-2,762
-11% -$21.4K 0.01% 1215
2021
Q3 		$243K Buy
26,028
+11,919
+84% +$136K 0.02% 865
2021
Q2 		$195K Buy
+14,109
New +$218K 0.02% 928

Other funds holding ONCR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Trexquant Investment's ONCR Position: Q1 2022 in Review

Trexquant Investment sold out of Oncorus, Inc. (ONCR) in Q1 2022, closing a stake of 23,266 shares — an estimated $123K sold.

Trexquant Investment first reported a position in ONCR in Q2 2021 and held it in 3 quarters. The position peaked at $243K in Q3 2021. 56 funds tracked by Wall St. Rank hold ONCR as of Q1 2022.

  • Trexquant Investment reported no remaining Oncorus, Inc. position as of Q1 2022 after selling out during the quarter.
  • Trexquant Investment sold 23,266 Oncorus, Inc. shares in Q1 2022, an estimated $123K.
  • Trexquant Investment first reported a position in Oncorus, Inc. in Q2 2021 and held it in 3 quarters.
  • Trexquant Investment's Oncorus, Inc. position peaked at $243K in Q3 2021.
  • 56 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q1 2022.

Based on Trexquant Investment's 13F filing for Q1 2022, filed 13 May 2022.